Clinical Trial Update: A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)

View source ↗

Summary

A Phase II clinical trial evaluating upfront pazopanib for metastatic clear cell renal cell carcinoma (Panther) is described, with current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Queen Mary University of London | Conditions: Metastatic Clear Cell Renal Cancer | Status: UNKNOWN